<p>Diploma PLC（伦敦证券交易所代码：DPLM - 获取免费报告）的股票在周三的午盘交易中达到了新的 52 周高点。该公司股票最高交易价为 6,965 便士，最后交易价为 6,960 便士，成交量为 578,314 股。该股票此前收盘价为 6,917.29 便士。</p>
<h2>分析师设定新的目标价格</h2>
<p>几位股票分析师最近对该公司进行了评估。Berenberg Bank 将 Diploma 的目标价格从 6,600 便士上调至 7,500 便士，并在 3 月 19 日的研究报告中给予该公司 “买入” 评级。Stifel Nicolaus 将 Diploma 的目标价格从 6,200 便士上调至 6,800 便士，并在 3 月 19 日的报告中给予该股票 “买入” 评级。摩根大通将 Diploma 的目标价格从 5,120 便士上调至 5,760 便士，并在 3 月 27 日的研究报告中给予该股票 “中性” 评级。Jefferies Financial Group 将 Diploma 的目标价格从 5,200 便士上调至 5,700 便士，并在 3 月 23 日的研究报告中给予该股票 “持有” 评级。最后，加拿大皇家银行将 Diploma 的目标价格从 6,200 便士上调至 6,600 便士，并在 3 月 19 日的研究报告中给予该公司 “跑赢大盘” 评级。五位股票研究分析师对该股票给予了 “买入” 评级，三位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，共识目标价格为 6,251.25 便士。</p>
<p><strong>阅读我们关于 Diploma 的最新股票分析</strong></p>
<h2>Diploma 股票表现</h2>
<p>该公司的 50 日简单移动平均线为 5,836.31 便士，200 日简单移动平均线为 5,572.35 便士。公司的债务与股本比率为 46.97，流动比率为 2.04，速动比率为 0.80。公司的市值为 92.9 亿英镑，市盈率为 50.47，市盈增长比率为 2.82，贝塔系数为 0.89。</p>
<h2>内部人士下注</h2>
<p>在相关消息中，内部人士 Ian El-Mokadem 在 3 月 20 日的交易中购买了 500 股该股票。该股票的平均购买价格为每股 5,820 便士，总交易额为 29,100 英镑。目前，1.14% 的股票由公司内部人士持有。</p>
<h2>关于 Diploma</h2>
<p>（获取免费报告）</p>
<p>Diploma PLC 及其子公司在英国、欧洲大陆、北美及国际市场上提供专业技术产品和服务。它通过三个业务部门运营：生命科学、密封件和控制。生命科学部门提供用于手术室和内窥镜手术的技术驱动产品；临床实验室的测试设备和服务；以及生物制药、食品安全和测试及其他研究导向产品。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票超过 Diploma</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Diploma 吗？</h2>
<p>在你考虑 Diploma 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Diploma 并不在名单上。</p>
<p>虽然 Diploma 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

DPLM

<p>Diploma PLC (伦敦证券交易所代码：DPLM) 在交易中达到了新的 52 周高点，达到 6965 便士，收盘价为 6960 便士。分析师们提高了他们的目标价格，Berenberg Bank 将新的目标定为 7500 便士，并维持 “买入” 评级。总体而言，五位分析师将该股票评级为 “买入”，三位评级为 “持有”，平均目标价格为 6251.25 便士。该公司的市值为 92.9 亿英镑，专注于各个行业的专业技术产品和服务</p>

<p>Shares of Diploma PLC (LON:DPLM - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 6,965 and last traded at GBX 6,960, with a volume of 578314 shares. The stock had previously closed at GBX 6,917.29.</p>
<div class="lb-trans"><p>Diploma PLC（伦敦证券交易所代码：DPLM - 获取免费报告）的股票在周三的午盘交易中达到了新的 52 周高点。该公司股票最高交易价为 6,965 便士，最后交易价为 6,960 便士，成交量为 578,314 股。该股票此前收盘价为 6,917.29 便士。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的目标价格</h2>
</div><p>Several equities analysts recently weighed in on the company. Berenberg Bank lifted their target price on Diploma from GBX 6,600 to GBX 7,500 and gave the company a &#34;buy&#34; rating in a research report on Thursday, March 19th. Stifel Nicolaus lifted their target price on Diploma from GBX 6,200 to GBX 6,800 and gave the stock a &#34;buy&#34; rating in a report on Thursday, March 19th. JPMorgan Chase &amp; Co. boosted their price objective on Diploma from GBX 5,120 to GBX 5,760 and gave the stock a &#34;neutral&#34; rating in a research note on Friday, March 27th. Jefferies Financial Group boosted their price objective on Diploma from GBX 5,200 to GBX 5,700 and gave the stock a &#34;hold&#34; rating in a research note on Monday, March 23rd. Finally, Royal Bank Of Canada upped their target price on Diploma from GBX 6,200 to GBX 6,600 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, March 19th. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus target price of GBX 6,251.25.</p>
<div class="lb-trans"><p>几位股票分析师最近对该公司进行了评估。Berenberg Bank 将 Diploma 的目标价格从 6,600 便士上调至 7,500 便士，并在 3 月 19 日的研究报告中给予该公司 “买入” 评级。Stifel Nicolaus 将 Diploma 的目标价格从 6,200 便士上调至 6,800 便士，并在 3 月 19 日的报告中给予该股票 “买入” 评级。摩根大通将 Diploma 的目标价格从 5,120 便士上调至 5,760 便士，并在 3 月 27 日的研究报告中给予该股票 “中性” 评级。Jefferies Financial Group 将 Diploma 的目标价格从 5,200 便士上调至 5,700 便士，并在 3 月 23 日的研究报告中给予该股票 “持有” 评级。最后，加拿大皇家银行将 Diploma 的目标价格从 6,200 便士上调至 6,600 便士，并在 3 月 19 日的研究报告中给予该公司 “跑赢大盘” 评级。五位股票研究分析师对该股票给予了 “买入” 评级，三位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “适度买入”，共识目标价格为 6,251.25 便士。</p>
</div><p><strong>Read Our Latest Stock Analysis on Diploma</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Diploma 的最新股票分析</strong></p>
</div><h2>Diploma Stock Performance</h2>
<div class="lb-trans"><h2>Diploma 股票表现</h2>
</div><p>The business has a fifty day simple moving average of GBX 5,836.31 and a two-hundred day simple moving average of GBX 5,572.35. The company has a debt-to-equity ratio of 46.97, a current ratio of 2.04 and a quick ratio of 0.80. The company has a market cap of £9.29 billion, a PE ratio of 50.47, a price-to-earnings-growth ratio of 2.82 and a beta of 0.89.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 5,836.31 便士，200 日简单移动平均线为 5,572.35 便士。公司的债务与股本比率为 46.97，流动比率为 2.04，速动比率为 0.80。公司的市值为 92.9 亿英镑，市盈率为 50.47，市盈增长比率为 2.82，贝塔系数为 0.89。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, insider Ian El-Mokadem bought 500 shares of the stock in a transaction on Friday, March 20th. The stock was bought at an average price of GBX 5,820 per share, for a total transaction of £29,100. 1.14% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Ian El-Mokadem 在 3 月 20 日的交易中购买了 500 股该股票。该股票的平均购买价格为每股 5,820 便士，总交易额为 29,100 英镑。目前，1.14% 的股票由公司内部人士持有。</p>
</div><h2>About Diploma</h2>
<div class="lb-trans"><h2>关于 Diploma</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.</p>
<div class="lb-trans"><p>Diploma PLC 及其子公司在英国、欧洲大陆、北美及国际市场上提供专业技术产品和服务。它通过三个业务部门运营：生命科学、密封件和控制。生命科学部门提供用于手术室和内窥镜手术的技术驱动产品；临床实验室的测试设备和服务；以及生物制药、食品安全和测试及其他研究导向产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Diploma</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Diploma</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Diploma Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Diploma 吗？</h2>
</div><p>Before you consider Diploma, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Diploma 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Diploma 并不在名单上。</p>
</div><p>While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Diploma 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Diploma（LON:DPLM）达到新的 52 周高点 - 你应该购买吗？